Breaking News
March 24, 2018 - Men have greater hospital readmission risk following firearm injury, study shows
March 24, 2018 - Pediatric psychologist shares 11 warning signs of childhood depression
March 24, 2018 - OncoBreak: ‘I Was Normal Once’; Ending Cervical Cancer; Mammo Controversy
March 24, 2018 - Gum Disease by the Numbers
March 24, 2018 - Studies show tool can identify individual needs, supports to help youths with autism, intellectual disabilities
March 24, 2018 - Study reveals cause of extreme nausea in pregnancy
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - NUST MISIS researchers produce elastic metal rods for scoliosis treatment
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
March 23, 2018 - Stony Brook Medicine expert provides tips for healthy diet to decrease cancer risk
March 23, 2018 - New findings could have revolutionary impact on quality of life of older people
March 23, 2018 - Restoring enzyme may help reverse effects of vascular aging, study shows
March 23, 2018 - Protein profiling reveals new prostate cancer mechanisms
March 23, 2018 - Depression may be linked to increased risk of atrial fibrillation
March 23, 2018 - FDA Takes Aim at Flavored Tobacco
March 23, 2018 - SMART Strategy Lowers Asthma Exacerbation Risk
March 23, 2018 - Cold open water plunge provides instant pain relief
March 23, 2018 - Portable and wearable technology supports future of military medical devices
March 23, 2018 - Patients with vascular malformations have poor health-related quality of life
March 23, 2018 - Researchers develop unique technology to overcome global antibiotic resistance crisis
March 23, 2018 - New DOD grant to support testing of promising therapy for triple-negative breast cancer
March 23, 2018 - Novel vaccine technologies can help better prepare for future infectious disease threats
March 23, 2018 - OncoBreak: Colonoscopy TV; Coverage for Genomic Testing; Care for Caregivers
March 23, 2018 - For some surgeries, nerve blocks mean better outcomes, fewer opioids
March 23, 2018 - Maternal obesity and androgen excess induce sex-specific anxiety in offspring, study suggests
March 23, 2018 - The tale of Theranos and the mysterious fire alarm
March 23, 2018 - USC researchers create algorithm to optimize substance abuse intervention groups
March 23, 2018 - Impulsivity may be associated with greater weight loss during treatment in obese children
March 23, 2018 - CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
March 23, 2018 - Senate Panel Addresses Native Americans’ Opioid Troubles
PrEP could make US easily hit its 2020 HIV prevention goal, study finds

PrEP could make US easily hit its 2020 HIV prevention goal, study finds

image_pdfDownload PDFimage_print
PrEP pills, which were found to be effective in preventing roughly three out of every 10 new HIV infections. Credit: NIAID.

If just a quarter of men who have same-sex intercourse and are at a high risk for HIV used daily preventive medicine, three out of every 10 HIV infections could be averted, according to a new Drexel University study.

Michael T. LeVasseur, PhD, and Neal D. Goldstein, PhD, from Drexel’s Dornsife School of Public Health, used a 10,000 person model of high-HIV-risk men who have sex with men (a term used for anyone who engages in same-sex intercourse, regardless of sexual orientation) to determine that prevention level. If it were achieved in the real world, it would more than surpass the United States’ National HIV/AIDS Strategy goal, which is to reduce new infections by 25 percent by 2020.

Their study specifically looked at how the use of a daily preventive drug, collectively called pre-exposure prophylaxis (PrEP) but sold under the brand-name Truvada, would affect HIV transmission rates. And they found that if any segment of the high-risk population used it, there would be an increase in prevention.

“We know that PrEP is highly effective at preventing HIV infection, what we don’t know is how much of an impact it will have at the population level considering the numerous behavioral strategies that men use to prevent infection,” LeVasseur said. “This study attempts to answer this question and future work with this model will attempt to identify specific strategies that will work best to stop the transmission of HIV.”

Published in the Journal of Acquired Immune Deficiency Syndromes, the study by LeVasseur, Goldstein, and their team doesn’t just look at PrEP use alone, but also other prevention methods, both on their own and mixed together. Those other methods included condom use, seroadapive behaviors (such as taking different positions during intercourse to reduce transmission risk) and treatment as prevention (which could reduce the “viral load” and make it less likely to transfer).

The cohort used in the study was compiled with data that would reflect a true-to-life 10,000 person population among urban, non-monogomous men who have sex with men, who were defined by the Center for Disease Control (CDC) as “high-risk.” All of the numbers were derived from the CDC’s study of 21 U.S. cities.

HIV-positive status was assigned to 19 percent of the cohort—44 percent of whom were unaware—and 36 percent of those in the study that were HIV-negative had not been tested in a year.

The researchers found that when PrEP was the only preventive strategy and used by just 1 percent of the HIV-negative population, it prevented 1.6 percent of infections in the model. And when the study team ratcheted the use up to 25 percent of the cohort, 30.7 percent of the infections that would have otherwise occurred were prevented.

Numbers for the other preventive techniques, used alone, were generated:

  • Condom use was found to prevent 48.8 percent of infections;
  • Seroadaptive behaviors, 37.7 percent
  • Treatment as prevention, 27.1 percent

When all of those efforts were combined, they resulted in the prevention of 72.2 percent of the infections that would have occurred. As such, the independent effect of PrEP was lowered. Still, though, it was found to prevent an additional 5 percent of infections, if 25 percent of the cohort used it.

“PrEP is just another ‘tool in the toolbox’ for HIV prevention, but it is an important one,” LeVasseur said. “PrEP can empower individuals who are in relationships where one person has HIV and the other doesn’t. It can also ease anxieties around HIV testing, as well as enhance sexual intimacy.”

However, PrEP uptake still remains low.

“It’s probably low because of a lack of knowledge among patients, as well as providers, coupled with high costs,” LeVasseur said.

Numbers of how little the uptake there is are difficult to come by, especially since it’s unclear how many men have same-sex intercourse, but “it’s likely true that the minority of eligible men” are taking it.

The company that makes Truvada—the brand-name PrEP—has made efforts to keep costs down, but “PrEP can still be very expensive, although most insurance companies now cover it.”

Results from the model show that the spread of PrEP is invaluable, and LeVasseur believes that not only can PrEP help bring down HIV numbers, it also has an added benefit in encouraging testing for all sexually transmitted infections, as well as a psychological benefit.

“Many men who have sex with men have felt significant anxiety around sexual intimacy due to fear of HIV infection, even with condom use, frequent HIV testing and seroadaptive techniques,” LeVasseur said. “Highlighting how effective these prevention methods are would certainly lead to an increase in PrEP uptake and easing of the mind.”

Explore further:
PrEP: A shield against AIDS

More information:
Michael T. LeVasseur et al, The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices, JAIDS Journal of Acquired Immune Deficiency Syndromes (2017). DOI: 10.1097/QAI.0000000000001555

Journal reference:
Journal of Acquired Immune Deficiency Syndromes

Provided by:
Drexel University

Tagged with:

About author

Related Articles